Aarti Drugs Limited has informed the Exchange about Credit Rating
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
ICRA Limited has reaffirmed the credit ratings on Aarti Drugs Limited's bank facilities totaling Rs. 1,452.80 crore. Long-term facilities — term loan of Rs. 253.13 crore, cash credit of Rs. 65 crore, and proposed term loan of Rs. 49.67 crore — retain [ICRA] AA- (Stable). Short-term fund and non-fund based facilities of Rs. 1,085 crore retain the highest [ICRA] A1+ rating. AA- is a high investment-grade rating, and A1+ is the top short-term grade, indicating strong financial health. The reaffirmation means the rating agency sees no change in the company's credit profile since its last review.
Reaffirmation of high-grade ratings signals strong financial standing, easy access to bank credit, and stable borrowing costs — all positive for shareholders. No rating change means no immediate impact on the stock price from this announcement.